Vion Biosciences, a life sciences company building differentiated capabilities across research, diagnostics and drug development workflows, has acquired Cellular Technology Limited (CTL), a provider of functional immune monitoring analyzers, software, consumables and services. This strategic acquisition strengthens Vion’s ability to quantify functional immune response across translational and clinical workflows. CTL’s technologies are widely used to measure T cell and B cell responses in appl...